IASO Pharma Inc.: Clinical Trials

1 trial sponsored by IASO Pharma Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow IASO Pharma Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy Study of Oral Zabofloxacin in Community Acquired Pneumonia
Zabofloxacin, Levofloxacin 500mg, Zabofloxacin 400mg - Community Acquired Pneumonia
Phase 2TerminatedIASO Pharma Inc.482010-03-012012-05-07

Conditions studied

Community-Acquired Pneumonia (1)  ·  Pneumonia (1)

Interventions

Levofloxacin (1)  ·  zabofloxacin (1)

Countries

United States (1)